Suchergebnisse - "Yamamoto, C"

PubPharm (527)

1

Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient [Corrigendum]

in: Infection and Drug Resistance | 2024

von Tanino Y | Nishioka K | Yamamoto C | +16

2

Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient

in: Infection and Drug Resistance | 2024

von Tanino Y | Nishioka K | Yamamoto C | +16

3

The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters : a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

enthalten in: Cardiovascular diabetology | 2017

von Kitao, N. | Miyoshi, H. | Furumoto, T. | +45

4

Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer : Japan Breast Cancer Research Network 05 Trial

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yamamoto, D. | Iwase, S. | Tsubota, Y. | +10

5

Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yamamoto, D. | Iwase, S. | Tsubota, Y. | +10

6

Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yamamoto, D. | Iwase, S. | Tsubota, Y. | +10

7

Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yamamoto, D. | Iwase, S. | Tsubota, Y. | +10

8

The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies

enthalten in: Gene therapy | 2015

von Tsukahara, T. | Iwase, N. | Kawakami, K. | +13

9

The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies

enthalten in: Gene therapy | 2015

von Tsukahara, T. | Iwase, N. | Kawakami, K. | +13

10

Analysis of hemolysis in collected bone marrow for bone marrow transplantation

enthalten in: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2013

von Sugimoto, M. | Fujiwara, S. | Hosonuma, R. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[53]